Response to Liu and Zhang

Elsa L S A van Liere^{1

2}, Nanne K H de Boer^{1

2}, Dewkoemar Ramsoekh^{1

2}

Affiliations

¹ Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
² Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam, the Netherlands .

Elsa L S A van Liere et al. Am J Gastroenterol. 2025.

. 2025 Mar 3;120(8):1876-1877.

doi: 10.14309/ajg.0000000000003346.

Elsa L S A van Liere^{1

2}, Nanne K H de Boer^{1

2}, Dewkoemar Ramsoekh^{1

2}

¹ Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
² Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam, the Netherlands .

No abstract available

References

1. Liu X, Zhang C-J. Comment on “Fecal immunochemical test to detect colorectal neoplasia in lynch syndrome: A prospective multicenter study”. Am J Gastroenterol 2025;120(8):1875–6.
1. van Liere ELSA, de Boer NKH, van Leerdam ME, et al. Fecal immunochemical test to detect colorectal neoplasia in Lynch syndrome: A prospective multicenter study. Am J Gastroenterol 2025;120(3):632–41.
1. Berwald G, Young GP, Cock C, et al. The diagnostic performance of fecal immunochemical tests for detecting advanced neoplasia at surveillance colonoscopy. Clin Gastroenterol Hepatol 2024;22(4):878–85.e2.
1. Digby J, Cleary S, Gray L, et al. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer. United Eur Gastroenterol J 2020;8(5):559–66.
1. Katsoula A, Paschos P, Haidich AB, et al. Diagnostic accuracy of fecal immunochemical test in patients at increased risk for colorectal cancer: A meta-analysis. JAMA Intern Med 2017;177(8):1110–8.